Aardvark Therapeutics, Inc.

AARD · Healthcare · Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate inna…

Aardvark Therapeutics, Inc. (AARD), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 1 purchase and 1 sale. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Sep 11 and filed Sep 12. The most active filer was Tien-Li Lee with 2 filings.

Add to watchlist

Filings, ttm

1 buy · 1 sell

Traders, ttm

2 insiders

Volume, ttmiDollar value disclosed in the window

$423K

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 11

Filed Sep 11

ADViAverage daily dollar volume

$1.3M

market data

Share price · 12M

$5.38 (-52.1%)

Adjusted for splits and dividends.

Volume by month

Buys $23.5M Sells $321K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Tien-Li Lee Chief Executive Officer 2 filings NS

Nelson Sun See Remarks 2 filings BC

Bihua Chen Other 1 filing DP Decheng Capital Global Life Sciences Fund IV, L.P. 10% owner 1 filing

Recent filings

Nelson SunSALE See Remarks $321K
62,000 sh × $5.18
Exec Sep 11
Filed Sep 11 · 8:14 PM ET Tien-Li LeePURCHASE Chief Executive Officer $101K
7,000 sh × $14.48
Exec Dec 11 2025
Filed Dec 12 2025 · 8:30 PM ET Bihua ChenPURCHASE Other $3.0M
187,500 sh × $16.00
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET Nelson SunPURCHASE Chief Financial Officer $160K
10,000 sh × $16.00
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET Tien-Li LeePURCHASE Chief Executive Officer $265K
16,542 sh × $16.00
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET Decheng Capital Global Life Sciences Fund IV, L.P.PURCHASE 10% owner $20.0M
1,250,000 sh across 2 lots
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET